Breaking News

Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics

New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

In order to expand its fill and finish capacity for the production of biologics and especially BSL1 and BSL2 vaccines against the SARS-CoV-2 virus, the Aenova Group is currently building a new sterile production area at its site in Latina, Italy. With an investment volume of more than €16 million, the focus is on a new “Fill and Finish” area for vials and prefilled syringes (PFS) with high-speed filling lines including compounding. The first line to be installed has a capacity of mor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters